Imatinib mesylate in the treatment of chronic myeloid leukemia: a local experience
This study was done to assess the overall response rate of imatinib mesylate in local patients with chronic myeloid leukaemia. A total of 69 patients were recruited with male/female ratio of 7:3. Of the 69 patients; 35% were in the chronic phase, 41% were in the accelerated phase, 17% were in blast...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Published: |
Malaysian Medical Association
2006
|
| Subjects: |